Veracyte, Inc.

Veracyte, Inc. is not a good value stock. Veracyte, Inc. is not very popular among insiders. Veracyte, Inc. is a mediocre stock to choose.
Log in to see more information.
Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. I...

News

Koss Olinger Consulting LLC Invests $257,000 in Veracyte, Inc. (NASDAQ:VCYT)
Koss Olinger Consulting LLC Invests $257,000 in Veracyte, Inc. (NASDAQ:VCYT)

Ticker Report Koss Olinger Consulting LLC acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm acquired 11,844 shares of the...\n more…

Veracyte, Inc. (NASDAQ:VCYT) Insider Sells $163,164.62 in Stock
Veracyte, Inc. (NASDAQ:VCYT) Insider Sells $163,164.62 in Stock

Ticker Report Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) insider John Leite sold 5,479 shares of the company's stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average...\n more…

Allspring Global Investments Holdings LLC Boosts Stock Position in Veracyte, Inc. (NASDAQ:VCYT)
Allspring Global Investments Holdings LLC Boosts Stock Position in Veracyte, Inc. (NASDAQ:VCYT)

Ticker Report Allspring Global Investments Holdings LLC boosted its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 18.7% in the second quarter, according to the company in its most recent 13F...\n more…

Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?
Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?

Zacks Investment Research A month has gone by since the last earnings report for Veracyte (VCYT). Shares have added about 9.2% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up...\n more…

The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks

Zacks Investment Research Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck.But how do you find the right...\n more…

Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors

Business Wire Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced the appointment of Brent Shafer and Tom Miller, Ph.D., to its board of directors, effective immediately. This...\n more…